Patents by Inventor David Eric Crump

David Eric Crump has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating pulmonary disease by administering an antibody to G-CSF
    Patent number: 9376682
    Abstract: The present invention relates generally to a method for treating or preventing or otherwise ameliorating the effects of pulmonary diseases characterized by or associated with infiltration of neutrophils and complications arising therefrom. The present invention further provides agents and pharmaceutical compositions comprising agents which inhibit the activity of G-CSF or its receptor, interfere with G-CSF signaling and/or which down-regulate expression of G-CSF or its receptor.
    Type: Grant
    Filed: October 1, 2013
    Date of Patent: June 28, 2016
    Assignee: CSL LIMITED
    Inventors: David Eric Crump, Andrew Donald Nash
  • TREATMENT OF PULMONARY DISEASE CONDITIONS
    Publication number: 20140056882
    Abstract: The present invention relates generally to a method for treating or preventing or otherwise ameliorating the effects of pulmonary diseases characterized by or associated with infiltration of neutrophils and complications arising therefrom. The present invention further provides agents and pharmaceutical compositions comprising agents which inhibit the activity of G-CSF or its receptor, interfere with G-CSF signaling and/or which down-regulate expression of G-CSF or its receptor.
    Type: Application
    Filed: October 1, 2013
    Publication date: February 27, 2014
    Applicant: CSL LIMITED
    Inventors: David Eric CRUMP, Andrew Donald NASH
  • Method of treating pulmonary disease by administering an antibody to G-CSF receptor
    Patent number: 8574572
    Abstract: The present invention relates generally to a method for treating or preventing or otherwise ameliorating the effects of pulmonary diseases characterized by or associated with infiltration of neutrophils and complications arising therefrom. The present invention further provides agents and pharmaceutical compositions comprising agents which inhibit the activity of G-CSF or its receptor, interfere with G-CSF signaling and/or which down-regulate expression of G-CSF or its receptor.
    Type: Grant
    Filed: August 10, 2007
    Date of Patent: November 5, 2013
    Assignee: CSL Limited
    Inventors: David Eric Crump, Andrew Donald Nash
  • TREATMENT OF PULMONARY DISEASE CONDITIONS
    Publication number: 20090324591
    Abstract: The present invention relates generally to a method for treating or preventing or otherwise ameliorating the effects of pulmonary diseases characterized by or associated with infiltration of neutrophils and complications arising therefrom. The present invention further provides agents and pharmaceutical compositions comprising agents which inhibit the activity of G-CSF or its receptor, interfere with G-CSF signaling and/or which down-regulate expression of G-CSF or its receptor.
    Type: Application
    Filed: August 10, 2007
    Publication date: December 31, 2009
    Applicant: CSL LIMITED
    Inventors: David Eric Crump, Andrew Donald Nash